SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $4,498,000 | +26.0% | 426,370 | +0.3% | 1.14% | +32.0% |
| Q4 2016 | $3,571,000 | +17.5% | 425,170 | +0.1% | 0.87% | +14.2% |
| Q3 2016 | $3,040,000 | -5.5% | 424,570 | +1.5% | 0.76% | -10.6% |
| Q2 2016 | $3,217,000 | +16.9% | 418,370 | +11.1% | 0.85% | +24.0% |
| Q1 2016 | $2,752,000 | -10.8% | 376,500 | -5.9% | 0.68% | +2.2% |
| Q4 2015 | $3,084,000 | +7.8% | 400,000 | 0.0% | 0.67% | +11.5% |
| Q3 2015 | $2,860,000 | -32.7% | 400,000 | 0.0% | 0.60% | -20.7% |
| Q2 2015 | $4,248,000 | -14.2% | 400,000 | 0.0% | 0.76% | -13.4% |
| Q1 2015 | $4,952,000 | +32.7% | 400,000 | 0.0% | 0.87% | +28.2% |
| Q4 2014 | $3,732,000 | -6.9% | 400,000 | 0.0% | 0.68% | -8.5% |
| Q3 2014 | $4,008,000 | -2.9% | 400,000 | 0.0% | 0.74% | +6.9% |
| Q2 2014 | $4,128,000 | -17.1% | 400,000 | 0.0% | 0.70% | -12.5% |
| Q1 2014 | $4,980,000 | +1.2% | 400,000 | 0.0% | 0.80% | -2.2% |
| Q4 2013 | $4,920,000 | +50.2% | 400,000 | +5.3% | 0.82% | +27.3% |
| Q3 2013 | $3,276,000 | +13.4% | 380,000 | +14.5% | 0.64% | -1.4% |
| Q2 2013 | $2,888,000 | – | 332,000 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $31,650,000 | 4.86% |
| Discovery Group I, LLC | 1,221,310 | $12,885,000 | 4.30% |
| Kenmare Capital Partners, L.L.C. | 389,177 | $4,106,000 | 3.98% |
| Profit Investment Management, LLC | 237,217 | $2,503,000 | 2.03% |
| Senvest Management, LLC | 2,202,272 | $23,234,000 | 1.66% |
| PERRITT CAPITAL MANAGEMENT INC | 426,370 | $4,498,000 | 1.14% |
| Camber Capital Management LP | 2,347,593 | $24,767,000 | 1.00% |
| DALTON GREINER HARTMAN MAHER & CO | 1,645,048 | $17,355,000 | 0.99% |
| Lapides Asset Management, LLC | 396,800 | $4,186,000 | 0.78% |
| DAFNA Capital Management LLC | 85,947 | $907,000 | 0.77% |